or Try an Advanced Search...

    Technical Analysis for RNA - Avidity Biosciences, Inc.

    Grade Last Price % Change Price Change
    D 36.88 -2.77% -1.05
    RNA closed down 2.77 percent on Thursday, December 5, 2024, on 1.18 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical RNA trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -2.77%
    Down 3 Days in a Row Weakness -2.77%
    Down 4 Days in a Row Weakness -2.77%
    Down 5 Days in a Row Weakness -2.77%
    Lower Bollinger Band Touch Weakness -2.77%
    Older End-of-Day Signals for RNA ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 8 hours ago
    Lower Bollinger Band Support about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    RNA Chart by TradingView
    Basic chart:

    Profile

    Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products

    Is RNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 26 Dyne, Avidity initiated at outperform by RBC on DM1 drugs
    Nov 14 Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
    Nov 14 RNA Stock Hits Record High on Entering the Cardiac Disease Space
    Nov 13 Avidity Bio Has Surged 416% This Year — And That's Before Today's 'Game-Changing' News
    Nov 13 Avidity Biosciences jumps 16%; reaches all-time high
    Nov 12 Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations
    Nov 9 Avidity Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 8 Avidity Biosciences reports Q3 results
    Nov 7 Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Lags Revenue Estimates
    Nov 7 Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
    See more RNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 56.0
    52 Week Low 6.79
    Average Volume 1,041,367
    200-Day Moving Average 36.25
    50-Day Moving Average 45.00
    20-Day Moving Average 43.83
    10-Day Moving Average 41.57
    Average True Range 2.69
    RSI (14) 33.33
    ADX 11.44
    +DI 19.15
    -DI 32.54
    Chandelier Exit (Long, 3 ATRs) 47.92
    Chandelier Exit (Short, 3 ATRs) 44.62
    Upper Bollinger Bands 51.40
    Lower Bollinger Band 36.27
    Percent B (%b) 0.04
    BandWidth 34.50
    MACD Line -1.78
    MACD Signal Line -0.98
    MACD Histogram -0.8029
    Fundamentals Value
    Market Cap 2.93 Billion
    Num Shares 79.4 Million
    EPS -3.00
    Price-to-Earnings (P/E) Ratio -12.29
    Price-to-Sales 113.02
    Price-to-Book 2.05
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 39.22
    Resistance 3 (R3) 39.36 38.73 38.83
    Resistance 2 (R2) 38.73 38.14 38.66 38.70
    Resistance 1 (R1) 37.81 37.77 37.49 37.66 38.57
    Pivot Point 37.17 37.17 37.02 37.10 37.17
    Support 1 (S1) 36.25 36.58 35.93 36.10 35.19
    Support 2 (S2) 35.62 36.21 35.54 35.06
    Support 3 (S3) 34.69 35.62 34.93
    Support 4 (S4) 34.54